Creutzfeldt-Jakob Syndrome
"Creutzfeldt-Jakob Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
Descriptor ID |
D007562
|
MeSH Number(s) |
C10.228.140.380.165 C10.228.228.800.230 F03.615.400.300
|
Concept/Terms |
Creutzfeldt-Jakob Syndrome- Creutzfeldt-Jakob Syndrome
- Creutzfeldt Jakob Syndrome
- Syndrome, Creutzfeldt-Jakob
- Creutzfeldt-Jakob Disease
- Creutzfeldt Jakob Disease
- Disease, Creutzfeldt-Jakob
- Jakob-Creutzfeldt Disease
- Disease, Jakob-Creutzfeldt
- Jakob Creutzfeldt Disease
- CJD (Creutzfeldt-Jakob Disease)
- CJD (Creutzfeldt Jakob Disease)
- Spongiform Encephalopathy, Subacute
- Encephalopathies, Subacute Spongiform
- Encephalopathy, Subacute Spongiform
- Spongiform Encephalopathies, Subacute
- Subacute Spongiform Encephalopathies
- Subacute Spongiform Encephalopathy
- Creutzfeldt Jacob Disease
- Disease, Creutzfeldt Jacob
- Jacob Disease, Creutzfeldt
- Jakob-Creutzfeldt Syndrome
- Jakob Creutzfeldt Syndrome
- Syndrome, Jakob-Creutzfeldt
Creutzfeldt-Jakob Disease, Familial- Creutzfeldt-Jakob Disease, Familial
- Creutzfeldt Jakob Disease, Familial
- Creutzfeldt-Jakob Diseases, Familial
- Disease, Familial Creutzfeldt-Jakob
- Familial Creutzfeldt-Jakob Diseases
- Familial Creutzfeldt-Jakob Disease
- Familial Creutzfeldt Jakob Disease
New Variant Creutzfeldt-Jakob Disease- New Variant Creutzfeldt-Jakob Disease
- New Variant Creutzfeldt Jakob Disease
- Creutzfeldt-Jakob Disease, Variant
- Creutzfeldt Jakob Disease, Variant
- Creutzfeldt-Jakob Disease, New Variant
- Creutzfeldt Jakob Disease, New Variant
- Variant Creutzfeldt-Jakob Disease
- Variant Creutzfeldt Jakob Disease
- V-CJD (Variant-Creutzfeldt-Jakob Disease)
- V CJD (Variant Creutzfeldt Jakob Disease)
|
Below are MeSH descriptors whose meaning is more general than "Creutzfeldt-Jakob Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Creutzfeldt-Jakob Syndrome".
This graph shows the total number of publications written about "Creutzfeldt-Jakob Syndrome" by people in this website by year, and whether "Creutzfeldt-Jakob Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 3 | 0 | 3 |
1996 | 2 | 0 | 2 |
1997 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2013 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Creutzfeldt-Jakob Syndrome" by people in Profiles.
-
Haldar S, Beveridge 'J, Wong J, Singh A, Galimberti D, Borroni B, Zhu X, Blevins J, Greenlee J, Perry G, Mukhopadhyay CK, Schmotzer C, Singh N. A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. Antioxid Redox Signal. 2013 Nov 10; 19(14):1662-75.
-
Kojima G, Tatsuno BK, Inaba M, Velligas S, Masaki K, Liow KK. Creutzfeldt-Jakob disease: a case report and differential diagnoses. Hawaii J Med Public Health. 2013 Apr; 72(4):136-9.
-
Bastian FO, Fermin CD. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases. Microsc Res Tech. 2005 Nov; 68(3-4):239-46.
-
Petersen RB, Siedlak SL, Lee HG, Kim YS, Nunomura A, Tagliavini F, Ghetti B, Cras P, Moreira PI, Castellani RJ, Guentchev M, Budka H, Ironside JW, Gambetti P, Smith MA, Perry G. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol. 2005 Sep; 110(3):232-8.
-
Kordek R, Liberski PP, Yanagihara R, Isaacson S, Gajdusek DC. Molecular analysis of prion protein (PrP) and glial fibrillary acidic protein (GFAP) transcripts in experimental Creutzfeldt-Jakob disease in mice. Acta Neurobiol Exp (Wars). 1997; 57(2):85-90.
-
Kordek R, Nerurkar VR, Liberski PP, Isaacson S, Yanagihara R, Gajdusek DC. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc Natl Acad Sci U S A. 1996 Sep 03; 93(18):9754-8.
-
Liberski PP, Yanagihara R, Brown P, Kordek R, Kloszewska I, Bratosiewicz J, Gajdusek DC. Microwave treatment enhances the immunostaining of amyloid deposits in both the transmissible and non-transmissible brain amyloidoses. Neurodegeneration. 1996 Mar; 5(1):95-9.
-
Biernat W, Liberski PP, Guiroy DC, Yanagihara R, Gajdusek DC. Proliferating cell nuclear antigen immunohistochemistry in astrocytes in experimental Creutzfeldt-Jakob disease and in human kuru, Creutzfeldt-Jakob disease and Gerstmann-Str?ussler-Scheinker syndrome. Neurodegeneration. 1995 Jun; 4(2):195-201.
-
Liberski PP, Budka H, Yanagihara R, Gajdusek DC. Neuroaxonal dystrophy in experimental Creutzfeldt-Jakob disease: electron microscopical and immunohistochemical demonstration of neurofilament accumulations within affected neurites. J Comp Pathol. 1995 Apr; 112(3):243-55.
-
Liberski PP, Nerurkar VR, Yanagihara R, Gajdusek DC. Tumor necrosis factor alpha (TNF-alpha) is involved in the pathogenesis of the panencephalopathic type of Creutzfeldt-Jakob disease. Mol Chem Neuropathol. 1995 Feb-Apr; 24(2-3):223-5.